ASTRO applauds bipartisan legislation to repeal the SGR and urges swift passage to strengthen Medicare and to protect patient care
Nearly 100 ASTRO members advocated in Washington for a permanent fix to the flawed SGR formula
Fairfax, Va., March 25, 2015 – The American Society for Radiation Oncology (ASTRO) commends Congressional leadership for introduction of the “Medicare Access and CHIP Reauthorization Act” (H.R. 2) and urges swift passage during votes in the House and Senate later this week. ASTRO also held its 12th Annual Advocacy Day efforts yesterday, with 97 ASTRO members convening in Washington, D.C., for more than 130 meetings with Congressional leaders from their home districts. In addition to this on-the-ground advocacy on Capitol Hill, ASTRO members across the country called on their legislators to seize this historic opportunity for a permanent fix to the sustainable growth rate (SGR) formula to preserve access and improve the quality of care for Medicare’s millions of beneficiaries.
The SGR, originally instituted in 2003, has been patched 17 times in the years since then, and a 21 percent rate reduction for all physicians is scheduled to take effect on April 1, 2015, if legislation is not passed in time. The permanent SGR fix would yield a new Medicare payment system that should stabilize reimbursement with a focus on higher quality care.
ASTRO also continues to encourage Congress to offset the costs of repealing the SGR and reauthorizing the Children’s Health Insurance Program (CHIP) with $3.5 billion in 10-year savings achieved from closing the physician self-referral loophole for radiation therapy, known as the in-office ancillary service (IOAS) exception. The President has recommended closing the IOAS exception in his budget three years in a row, including the Fiscal Year 2016 Budget, and this delivery system reform policy is supported by several bipartisan group, as well as AARP.
“We are at a turning point for our nation’s health care system. Permanently fixing the SGR with the comprehensive plan outlined in this legislation would be significant. A stabilized reimbursement plan would strengthen Medicare and allow us to improve quality faster for our patients,” said Bruce G. Haffty, MD, FASTRO, Chair of ASTRO’s Board of Directors. “ASTRO members across the country provide life-saving radiation therapy to more than one million cancer patients each year, and passage of this legislation will help us accelerate our primary mission—curing cancer. We commend the bipartisan Congressional leadership for these proposals and urge immediate passage to end the short-term patches and realign physician reimbursement with both value and quality of care. As Congress continues to examine needed Medicare delivery system reforms, we urge closing the physician self-referral loophole to further reinforce patient-centered care and to realize significant savings that can help offset the costs of health care priorities, including the SGR repeal and CHIP reauthorization.”
The legislation would increase physician pay by 0.5 percent in the second half of 2015, and then an additional 0.5 percent annually from 2016 through the end of 2019; the 2019 rates would be maintained through 2025 with no additional increases. The bills also include comprehensive structural changes to Medicare’s reimbursement model that would promote physician participation in clinical quality improvement activities and value-based, quality care that would take full effect in 2019. In addition, current Medicare programs that reward electronic health records, quality reporting, the value-based modifier and meaningful use would be merged by 2019 to encourage participation and to reduce the administrative burden. The total package for the SGR fix is estimated to cost more than $200 billion over the next 10 years, of which approximately $70 billion would by offset by additional Medicare policy changes.
ASTRO is the premier radiation oncology society in the world, with nearly 11,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology • Biology • Physics ( www.redjournal.org ) and Practical Radiation Oncology ( www.practicalradonc.org ); developed and maintains an extensive patient website, www.rtanswers.org ; and created the Radiation Oncology Institute ( www.roinstitute.org ), a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org .